| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 7 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | United States | 3 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | Israel | 1 | |
| #7 | Japan | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Singapore | 1 | |
| #10 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Chemical engineering |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Separation | |
| #5 | Microorganisms | |
| #6 | Microbiology | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Dendamrongvit Wiphusanee | 7 |
| #2 | Yonan Chris | 7 |
| #3 | Gangloff Scott | 6 |
| #4 | Healy-Fried Martha | 5 |
| #5 | Taddei Maria | 5 |
| #6 | Santoro Marc | 4 |
| #7 | Jose Kevin John | 4 |
| #8 | Madabhushi Sri | 4 |
| #9 | Cini John | 3 |
| #10 | Nagi Athena | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AU2019256289A1 | Buffered formulations of bevacizumab for use of treating diseases | |
| AU2017205477A1 | Methods for separating isoforms of monoclonal antibodies | |
| AU2017206012A1 | Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition | |
| EP3397281A1 | Buffered formulations of bevacizumab |